Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry"

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 2, 2008, Pages 161-166

  Gujral, Sumeet ^a   Subramanian, P ^a   Patkar, Nikhil ^b   Badrinath, Y ^a   Kumar, Ashok ^a   Tembhare, Prashant ^a   Vazifdar, Archana ^c   Khodaiji, Shenaj ^d   Madkaikar, Manisha ^e   Ghosh, Kanjaksha ^e   Yargop, Mamta ^f   Dasgupta, Amar ^g  

^a TATA MEMORIAL HOSPITAL   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c BOMBAY HOSPITAL   (India)

^d P D HINDUJA NATIONAL HOSPITAL   (India)

^e KEM HOSPITAL   (India)

^f JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^g Ranbaxy Laboratories Limited   (India)

Author keywords

Flow cytometry; Guidelines; Immunophenotyping

Indexed keywords

ANTIBODY; CD103 ANTIGEN; CD19 ANTIBODY; CD2 ANTIGEN; CD20 ANTIBODY; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA;

ACUTE LEUKEMIA; ANTIBODY SCREENING; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE MARKER; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HEMATOLYMPHOID NEOPLASM; IMMUNOPHENOTYPING; LABORATORY DIAGNOSIS; LYMPHATIC SYSTEM TUMOR; LYMPHOPROLIFERATIVE DISEASE; PLASMA CELL DYSCRASIA; PRACTICE GUIDELINE;

CONSENSUS; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; IMMUNOPHENOTYPING; INDIA; LEUKEMIA; LYMPHOMA; PRACTICE GUIDELINES AS TOPIC;

EID: 46949085745     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.41602     Document Type: Conference Paper

References (13)

1. World Health Organization classification of tumors. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyons, France: IARC Press; 2001. p. 75-118.
2. nd ed. CLSI document H43-A2 [ISBN 1-56238-000-0]. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute; 2006. p. 19087-1898.
3. Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations. Cytometry 1997;30:231-5.
4. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, et al. 2006 Bethesda international consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry 2007;72:S14-22.
5. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias: European Group for the Immunological characterization of Leukemias (EGIL). Leukemia 1995;9:1783-6.
6. Campana D, Behm FG. Immunophenotyping of leukemia. J Immunol Met 2000;243:59-75.
7. Hasset J, Parker J. Laboratory practices in reporting flow cytometery phenotyping results for leukemia/lemphoma specimens: Results of a survey. Cytometry 1995;22:264-81.
8. McCoy JP Jr, Overton WR. A survey of current practices in clinical flow cytometry. Am J Clin Pathol 1996;106:82-6.
9. Braylan RC, Orfao A, Borowitz MJ, Davis BH. Optimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meeting. Cytometry 2001;46:23-7.
10. Bain BJ, Barnett D, Linch D, Matutes E, Reilly JT. General haematology task force of the british committee for standards in haematology (BCSH), British Society of Haematology. Revised guideline on immunophenotyping in acute leukemia and chronic lymphoproliferative disorders. Clin Lab Hematol 2002;24:1-13.
11. Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry 2005;70:39-44.
12. Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D, et al. 2006 Bethesda International Consensus Recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasms: Medical Indications. Cytometry 2007;72:S5-13.
13. Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: Basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 2002;16:1460-9.